Larvol Delta - Safety-and-Tolerability-of-a-Single-Subcutaneous-Dose-of-AntiAngiogenesis-Drug-to-Treat-Neovascular-Agerelated-Macular-Degeneration-wet-AMD-and-Diabetic-Macular-Edema-DME

D-4517.2 - Ashvattha Therap

https://arvo2022.arvo.org/meetings/mEasGFboENcLMRgJq

Jeffrey Cleland; Rishi Sharma; Santiago Appiani; Jerome Moore; Brian Rogers

Apr 29, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next